Comparison of tenofovir and entecavir in patients with chronic HBV infection

CEYLAN B., YARDIMCI C., FINCANCI M., EREN G., TOZALGAN U., MUDERRISOGLU C., ...Daha Fazla

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, cilt.17, sa.18, ss.2467-2473, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 17 Sayı: 18
  • Basım Tarihi: 2013
  • Dergi Adı: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.2467-2473
  • Anahtar Kelimeler: Entecavir, Tenofovir, Hepatitis B virus, CHRONIC HEPATITIS-B, DISOPROXIL-FUMARATE, E-ANTIGEN, NUCLEOSIDE-NAIVE, EFFICACY, VIRUS, LAMIVUDINE, ADEFOVIR, SAFETY
  • Bezmiâlem Vakıf Üniversitesi Adresli: Evet

Özet

BACKGROUND: Sustained suppression of serum HBV DNA levels with nucleos(t)ide analogues is the most important success obtained in the treatment of chronic HBV infection today. Tenofovir and entecavir provide more robust viral suppression.